-
- Phase 2 trials showed the drug was safe, well tolerated and produced clinically relevant biological activity http://www.hgsi.com/belimumab.html
- Discovered: July 1994
- Developed by: Human Genome Sciences and GlaxoSmithKline
- Common uses: Treatment of lupus, rheumatoid arthritis and autoimmune diseases
- Generic name: Belimumab
- Also known as: LymphoStat-B
- Phase 3 trails approved by the FDA in October of 2006 http://www.hgsi.com/belimumab.html
- Works to suppress the B-lymphocyte stimulator, an antibody that attacks the body's healthy tissues http://www.hgsi.com/belimumab.html
-
-
Benlysta is an experimental prescription drug that controls the immune system to help lupus patients. The drug was in clinical tests as of July 20, 2009, but said to be working as intended.
-
view more fast facts...



